Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey

Basit Öğe Kaydı
dc.contributor.authorDegertekin, Halil
dc.contributor.authorYalcin, Kendal
dc.contributor.authorYakut, Mustafa
dc.contributor.authorYurdaydin, Cihan
dc.date.accessioned2024-04-24T17:11:36Z
dc.date.available2024-04-24T17:11:36Z
dc.date.issued2008
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: Recent reports suggest a decline of delta hepatitis (DH) in the West as well as in the Far East. Aim: To study the DH seroepidemiology in Turkey. Methods: Statistical power analysis was utilized based on data available in a recent article using prevalence figure estimates. Binominal distribution was applied in order to assess the number of samples required to estimate the prevalence with a given precision. Results: Out of 62 studies in the original study, 32 were eliminated because of insufficient power. A total of 6734 patients (5231 with chronic hepatitis and 1503 with cirrhosis) were analysed. Anti-HDV seropositivity among patients with chronic hepatitis B (CHB) and hepatitis B-induced cirrhosis was lowest in the west of the country and highest in the southeast (5 vs. 27%, P < 0.0001 and 20 vs. 46%, P < 0.0001) respectively. Compared with data obtained before 1995, after 1995, DH prevalence in patients with CHB and cirrhosis decreased from 29 to 12% (P < 0.0001) and from 38 to 27% (P=0.03) in central and southeast Turkey and from 38 to 20% (P < 0.0001) and from 66 to 46% (P < 0.002) in west and southeast Turkey respectively. Conclusion: Despite the decrease of its prevalence in Turkey, DH remains a significant health problem in parts of the country with low socio-economic level.en_US
dc.identifier.doi10.1111/j.1478-3231.2008.01673.x
dc.identifier.endpage498en_US
dc.identifier.issn1478-3223
dc.identifier.issn1478-3231
dc.identifier.issue4en_US
dc.identifier.pmid18339076
dc.identifier.scopus2-s2.0-40949119532
dc.identifier.scopusqualityQ1
dc.identifier.startpage494en_US
dc.identifier.urihttps://doi.org/10.1111/j.1478-3231.2008.01673.x
dc.identifier.urihttps://hdl.handle.net/11468/17623
dc.identifier.volume28en_US
dc.identifier.wosWOS:000253980300011
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofLiver International
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic Hepatitis B And Cirrhosisen_US
dc.subjectDelta Hepatitisen_US
dc.subjectSeroepidemiologyen_US
dc.subjectTurkeyen_US
dc.titleSeropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkeyen_US
dc.titleSeropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu